Archives:

2013 , 2012 , 2011 , 2010 , 2009 , 2008 , 2007 , 2006 , 2005 , 2004 , 2003 , 2002

November 8 CASMED Reports Q3 2011 Results
November 1 CASMED Announces Third Quarter 2011 Earnings Release Date and Conference Call Information
October 27 New Study Shows Superior Accuracy of FORE-SIGHT Oximetry
September 1 CASMED to Present at the Rodman & Renshaw 13th Annual Healthcare Conference
August 10 CASMED Reports Q2 2011 Results
August 3 CASMED Announces Second Quarter 2011 Earnings Release Date and Conference Call Information
July 28 CASMED Announces Addition of Two Key Sales Executives
June 15 MEDLINE AND CASMED ANNOUNCE DISTRIBUTION PARTNERSHIP FOR CO-BRANDED VITAL SIGNS MONITORS
June 9 CASMED Raises $15 Million in Private Placement
May 11 CASMED Reports Q1 2011 Results
May 4 CASMED Announces First Quarter 2011 Earnings Release Date and Conference Call Information
March 2 CASMED Reports Fourth Quarter and Full Year 2010 Results
February 23 CASMED Announces Fourth Quarter and Year End 2010 Earnings Release Date and Conference Call Information
January 18 CASMED Receives FDA Clearance For Non-Cerebral Indication of FORE-SIGHT Absolute Tissue Oximeter
January 10 CASMED Announces Key Addition to Executive Management Team
January 10 CASMED Reports Inducement Grants to VP of Sales and Marketing Matthew J. Herwig Under NASDAQ Marketplace Rule 5635

Press Releases